Aerosol is suspension of liquid or solid particles in a carrier gas, which makes use of it for treatment of respiratory system related diseases. Different forms of drugs can be utilized for aerosol therapy such as solid particles, liquid particles, solutions, and suspensions. Until recently, aerosol therapy concentrated primarily on treatment of asthma and COPD for which, pressurized metered-dose inhaler device was used. However, the role of aerosol therapy is expanding beyond the initial focus. This expansion eliminated CFC-based traditional metered-dose inhalers devices. This will ultimately boost the market growth of aerosol therapy in the field of gene therapy, inhalation therapy and vaccination. Aerosol therapy is a natural and easiest way to treat asthma, COPD, cystic fibrosis, and broncho pulmonary dysplasia (BPD). Aerosol therapy is also used to deliver insulin, vaccines of influenza and measles, and pain medications. Aerosol treatment therapy gives an excellent and cost-efficient drug delivery. This therapy is effective for patients who cannot use metered-dose inhalers; primary inhalation devices are produced that guarantee breath-actuated aerosol delivery with minimal side effects.

Scope of the Report:

This report studies the Aerosol Therapy market status and outlook of Global and major regions, from angles of players, countries, product types and end industries; this report analyzes the top players in global market, and splits the Aerosol Therapy market by product type and applications/end industries.

Currently metered dose inhaler majorly contributes to the market and is expected to dominate the market over the forecast period. As per the data, COPD is third leading cause of death and fifth leading cause of disability. Also, factors like increasing pollution, improper lifestyles are the factors that drive the growth of the market.

The global Aerosol Therapy market is valued at xx million USD in 2017 and is expected to reach xx million USD by the end of 2023, growing at a CAGR of xx% between 2017 and 2023.

The Asia-Pacific will occupy for more market share in following years, especially in China, also fast growing India and Southeast Asia regions.

North America, especially The United States, will still play an important role which cannot be ignored. Any changes from United States might affect the development trend of Aerosol Therapy.

Europe also play important roles in global market, with market size of xx million USD in 2017 and will be xx million USD in 2023, with a CAGR of xx%.

Market Segment by Companies, this report covers

Merck

Boehringer Ingelheim

GlaxoSmithKline

AstraZeneca

Novartis

Teva Pharmaceuticals

Opko Health

Omron Healthcare

Covidien

GE Healthcare

Philips Healthcare

Agilent Technologies

GF Health Products

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Inhalers

Nebulizers

Bronchodilators

Market Segment by Applications, can be divided into

Hospitals

Clinics

Ambulatory Surgical Centers

Individual

Table of Contents

1 Aerosol Therapy Market Overview

1.1 Product Overview and Scope of Aerosol Therapy

1.2 Classification of Aerosol Therapy by Types

1.2.1 Global Aerosol Therapy Revenue Comparison by Types (2017-2023)

1.2.2 Global Aerosol Therapy Revenue Market Share by Types in 2017

1.2.3 Inhalers

1.2.4 Nebulizers

1.2.5 Bronchodilators

1.3 Global Aerosol Therapy Market by Application

1.3.1 Global Aerosol Therapy Market Size and Market Share Comparison by Applications (2013-2023)

1.3.2 Hospitals

1.3.3 Clinics

1.3.4 Ambulatory Surgical Centers

1.3.5 Individual

1.4 Global Aerosol Therapy Market by Regions

1.4.1 Global Aerosol Therapy Market Size (Million USD) Comparison by Regions (2013-2023)

1.4.1 North America (USA, Canada and Mexico) Aerosol Therapy Status and Prospect (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy) Aerosol Therapy Status and Prospect (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Aerosol Therapy Status and Prospect (2013-2023)

1.4.4 South America (Brazil, Argentina, Colombia) Aerosol Therapy Status and Prospect (2013-2023)

1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Aerosol Therapy Status and Prospect (2013-2023)

1.5 Global Market Size of Aerosol Therapy (2013-2023)

2 Manufacturers Profiles

2.1 Merck

2.1.1 Business Overview

2.1.2 Aerosol Therapy Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Merck Aerosol Therapy Revenue, Gross Margin and Market Share (2016-2017)

2.2 Boehringer Ingelheim

2.2.1 Business Overview

2.2.2 Aerosol Therapy Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 Boehringer Ingelheim Aerosol Therapy Revenue, Gross Margin and Market Share (2016-2017)

2.3 GlaxoSmithKline

2.3.1 Business Overview

2.3.2 Aerosol Therapy Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 GlaxoSmithKline Aerosol Therapy Revenue, Gross Margin and Market Share (2016-2017)

2.4 AstraZeneca

2.4.1 Business Overview

2.4.2 Aerosol Therapy Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 AstraZeneca Aerosol Therapy Revenue, Gross Margin and Market Share (2016-2017)

2.5 Novartis

2.5.1 Business Overview

2.5.2 Aerosol Therapy Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Novartis Aerosol Therapy Revenue, Gross Margin and Market Share (2016-2017)

2.6 Teva Pharmaceuticals

2.6.1 Business Overview

2.6.2 Aerosol Therapy Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 Teva Pharmaceuticals Aerosol Therapy Revenue, Gross Margin and Market Share (2016-2017)

2.7 Opko Health

2.7.1 Business Overview

2.7.2 Aerosol Therapy Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Opko Health Aerosol Therapy Revenue, Gross Margin and Market Share (2016-2017)

2.8 Omron Healthcare

2.8.1 Business Overview

2.8.2 Aerosol Therapy Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Omron Healthcare Aerosol Therapy Revenue, Gross Margin and Market Share (2016-2017)

2.9 Covidien

2.9.1 Business Overview

2.9.2 Aerosol Therapy Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Covidien Aerosol Therapy Revenue, Gross Margin and Market Share (2016-2017)

2.10 GE Healthcare

2.10.1 Business Overview

2.10.2 Aerosol Therapy Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 GE Healthcare Aerosol Therapy Revenue, Gross Margin and Market Share (2016-2017)

2.11 Philips Healthcare

2.11.1 Business Overview

2.11.2 Aerosol Therapy Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Philips Healthcare Aerosol Therapy Revenue, Gross Margin and Market Share (2016-2017)

2.12 Agilent Technologies

2.12.1 Business Overview

2.12.2 Aerosol Therapy Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Agilent Technologies Aerosol Therapy Revenue, Gross Margin and Market Share (2016-2017)

2.13 GF Health Products

2.13.1 Business Overview

2.13.2 Aerosol Therapy Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 GF Health Products Aerosol Therapy Revenue, Gross Margin and Market Share (2016-2017)

3 Global Aerosol Therapy Market Competition, by Players

3.1 Global Aerosol Therapy Revenue and Share by Players (2013-2018)

3.2 Market Concentration Rate

3.2.1 Top 5 Aerosol Therapy Players Market Share

3.2.2 Top 10 Aerosol Therapy Players Market Share

3.3 Market Competition Trend

4 Global Aerosol Therapy Market Size by Regions

4.1 Global Aerosol Therapy Revenue and Market Share by Regions

4.2 North America Aerosol Therapy Revenue and Growth Rate (2013-2018)

4.3 Europe Aerosol Therapy Revenue and Growth Rate (2013-2018)

4.4 Asia-Pacific Aerosol Therapy Revenue and Growth Rate (2013-2018)

4.5 South America Aerosol Therapy Revenue and Growth Rate (2013-2018)

4.6 Middle East and Africa Aerosol Therapy Revenue and Growth Rate (2013-2018)

5 North America Aerosol Therapy Revenue by Countries

5.1 North America Aerosol Therapy Revenue by Countries (2013-2018)

5.2 USA Aerosol Therapy Revenue and Growth Rate (2013-2018)

5.3 Canada Aerosol Therapy Revenue and Growth Rate (2013-2018)

5.4 Mexico Aerosol Therapy Revenue and Growth Rate (2013-2018)

6 Europe Aerosol Therapy Revenue by Countries

6.1 Europe Aerosol Therapy Revenue by Countries (2013-2018)

6.2 Germany Aerosol Therapy Revenue and Growth Rate (2013-2018)

6.3 UK Aerosol Therapy Revenue and Growth Rate (2013-2018)

6.4 France Aerosol Therapy Revenue and Growth Rate (2013-2018)

6.5 Russia Aerosol Therapy Revenue and Growth Rate (2013-2018)

6.6 Italy Aerosol Therapy Revenue and Growth Rate (2013-2018)

7 Asia-Pacific Aerosol Therapy Revenue by Countries

7.1 Asia-Pacific Aerosol Therapy Revenue by Countries (2013-2018)

7.2 China Aerosol Therapy Revenue and Growth Rate (2013-2018)

7.3 Japan Aerosol Therapy Revenue and Growth Rate (2013-2018)

7.4 Korea Aerosol Therapy Revenue and Growth Rate (2013-2018)

7.5 India Aerosol Therapy Revenue and Growth Rate (2013-2018)

7.6 Southeast Asia Aerosol Therapy Revenue and Growth Rate (2013-2018)

8 South America Aerosol Therapy Revenue by Countries

8.1 South America Aerosol Therapy Revenue by Countries (2013-2018)

8.2 Brazil Aerosol Therapy Revenue and Growth Rate (2013-2018)

8.3 Argentina Aerosol Therapy Revenue and Growth Rate (2013-2018)

8.4 Colombia Aerosol Therapy Revenue and Growth Rate (2013-2018)

9 Middle East and Africa Revenue Aerosol Therapy by Countries

9.1 Middle East and Africa Aerosol Therapy Revenue by Countries (2013-2018)

9.2 Saudi Arabia Aerosol Therapy Revenue and Growth Rate (2013-2018)

9.3 UAE Aerosol Therapy Revenue and Growth Rate (2013-2018)

9.4 Egypt Aerosol Therapy Revenue and Growth Rate (2013-2018)

9.5 Nigeria Aerosol Therapy Revenue and Growth Rate (2013-2018)

9.6 South Africa Aerosol Therapy Revenue and Growth Rate (2013-2018)

10 Global Aerosol Therapy Market Segment by Type

10.1 Global Aerosol Therapy Revenue and Market Share by Type (2013-2018)

10.2 Global Aerosol Therapy Market Forecast by Type (2018-2023)

10.3 Inhalers Revenue Growth Rate (2013-2023)

10.4 Nebulizers Revenue Growth Rate (2013-2023)

10.5 Bronchodilators Revenue Growth Rate (2013-2023)

11 Global Aerosol Therapy Market Segment by Application

11.1 Global Aerosol Therapy Revenue Market Share by Application (2013-2018)

11.2 Aerosol Therapy Market Forecast by Application (2018-2023)

11.3 Hospitals Revenue Growth (2013-2018)

11.4 Clinics Revenue Growth (2013-2018)

11.5 Ambulatory Surgical Centers Revenue Growth (2013-2018)

11.6 Individual Revenue Growth (2013-2018)

12 Global Aerosol Therapy Market Size Forecast (2018-2023)

12.1 Global Aerosol Therapy Market Size Forecast (2018-2023)

12.2 Global Aerosol Therapy Market Forecast by Regions (2018-2023)

12.3 North America Aerosol Therapy Revenue Market Forecast (2018-2023)

12.4 Europe Aerosol Therapy Revenue Market Forecast (2018-2023)

12.5 Asia-Pacific Aerosol Therapy Revenue Market Forecast (2018-2023)

12.6 South America Aerosol Therapy Revenue Market Forecast (2018-2023)

12.7 Middle East and Africa Aerosol Therapy Revenue Market Forecast (2018-2023)

13 Research Findings and Conclusion

14 Appendix

14.1 Methodology

14.2 Data Source

List of Tables and Figures

Figure Aerosol Therapy Picture

Table Product Specifications of Aerosol Therapy

Table Global Aerosol Therapy and Revenue (Million USD) Market Split by Product Type